Skip to main navigation Skip to search Skip to main content

Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: A cause for concern?

  • Frank Firkin

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Pages (from-to)977-978
Number of pages2
JournalLeukemia and Lymphoma
Volume55
Issue number5
DOIs
Publication statusPublished - 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this